期刊文献+

中性粒细胞百分比与白蛋白比值对急性ST段抬高型心肌梗死患者预后的预测价值分析 被引量:11

Prognostic value of neutrophil percentage-albumin ratio in patients with acute ST-segment elevation myocardial infarction
原文传递
导出
摘要 目的:探讨中性粒细胞百分比与白蛋白比值(NPAR)对急性ST段抬高型心肌梗死(STEMI)患者的预后预测价值。方法:回顾性分析2016-07-2017-11期间我院急诊科收治的476例STEMI患者的临床资料、实验室检查以及预后情况。根据STEMI患者入院时的NPAR三分位间距,分为A组(159例)、B组(159例)、C组(158例),采用多因素Cox回归分析STEMI患者全因死亡的独立风险因子。结果:C组比A组和B组具有更高的住院病死率(13.3%vs.3.8%vs.1.3%,P<0.01)和远期病死率(22.8%vs.5.0%vs.7.5%,P<0.01),差异均有统计学意义。Kaplan-Meier生存曲线分析显示C组累计生存率低于A组和B组(77.2%vs.95.0%vs.92.5%,P<0.01)。多因素COX回归分析显示,入院时NPAR是STEMI患者全因死亡的独立危险因素[(Avs.B)HR=4.595,95%CI:1.126~18.753,P=0.034;(Avs.C)HR=7.292,95%CI:1.926~27.610,P=0.003]。结论:在急诊早期,NPAR是预测STEMI患者死亡风险的有效工具,有助于指导临床决策。 Objective:To investigate the prognostic value of neutrophil percentage-albumin ratio(NPAR)in patients with acute ST segment elevation myocardial infarction(STEMI).Method:The clinical data,laboratory examination and prognosis of 476 STEMI patients admitted to the emergency department of West China Hospital from July 2016 to November 2017 were analyzed retrospectively.According to the triad interval of NPAR at admission,STEMI patients were divided into group A(n=159),group B(n=159)and group C(n=158).The independent risk factors of all-cause death in STEMI patients were analyzed by multivariate Cox regression.Result:Group C had higher in-hospital mortality(13.3%vs.3.8%vs.1.3%,P<0.01)and long-term mortality(22.8%vs.5.0%vs.7.5%,P<0.01)than group A and group B.Kaplan Meier survival curve analysis showed that the cumulative survival rate of group C was lower than that of group A and group B(77.2%vs.95.0%vs.92.5%,P<0.01).Multivariate Cox regression analysis showed that NPAR was an independent risk factor for all-cause death of STEMI patients[(A vs.B)HR=4.595,95%CI:1.126-18.753,P=0.034;(A vs.C)HR=7.292,95%CI:1.926-27.610,P=0.003].Conclusion:NPAR is an useful tool to predict the risk of death for STEMI patients,which is helpful to guide clinical decision-making in the early stage at emergency.
作者 张芹 程毅松 贾禹 李东泽 邹利群 高永莉 叶磊 万智 ZHANG Qin;CHENG Yisong;JIA Yu;LI Dongze;ZOU Liqun;GAO Yongli;YE Lei;WAN Zhi(Department of Emergency,West China Hospital of Sichuan University,Disaster Medical Cente of Sichuan University,Emergency and Trauma Nursing of West China Nursing College,Chengdu,610041,China)
出处 《临床急诊杂志》 CAS 2020年第5期354-358,共5页 Journal of Clinical Emergency
基金 四川省科学技术项目(No:20ZDYF2813、2019JDRC0105、2017SZ0190) 四川大学华西医院学科卓越发展1·3·5工程临床研究孵化项目(No:2018HXFH027)。
关键词 急性ST段抬高型心肌梗死 中性粒细胞百分比 白蛋白 预后 acute ST-segment elevation myocardial infarction neutrophil percentage albumin prognosis
  • 相关文献

参考文献2

二级参考文献41

  • 1Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 2LLOYD - JONES 0, ADAMS RJ, BROWN TM, et 01. Executive summary: heart disease and stroke statistics- 2010 update. A report from the American Heart Associaton[J]. Circulation, 2010, 121 (7): 948-954.
  • 3STIERMAIER T, DESCH S, SCHULER G, et 01. Reperfusion strategies in ST - segment elevation myocardial infarction[J] . Minerva Med, 2013, 104 ( 4): 391-411.
  • 4TOPOL EJ, CALIFF RM, DEORGE OJ, et 01. A randomizedtrial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardialinfarction[J]. N Engl J Med, 1987, 317 (10): 581-588.
  • 5SIMOONS ML, ARNOLD AE, BIETRIU A, et 01. Thrombolysiswith tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronaryangioplasty[J]. Lancet, 1988, 331(8579): 197-203.
  • 6The TIMI Research Group. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. The TIMI II A results[J]. JAMA, 1988, 260(18): 2849-2858.
  • 7ROGERSWJ, BAlM OS, GORE JM, et 01. Comparison ofimmediate invasive, delayed invasive, and conservative strategies after tissue - type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMl) Phase II-A trialjJ]. Circulation, 1990, 81 (5): 1457-1476.
  • 8The SWIFT Trial Research Group. SWIFT trial of delayedelective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction[J]. BMJ, 1991,302(6776): 555-560.
  • 9WALLER BP, ROTHBAUM DA, PINKERTON CA, et al. Statusof the myocardium and infarct related coronary artery in 10 necropsy patients with acute recanalization using pharmacologic (streptokinase, r - tissue plasminogen activator), mechanical (percut-aneous transluminal coronary angioplasty ) , or combined types of reperfusion therapy[J]. J Am Coil Cardiol , 1987, 9 (4) : 785-801.
  • 10KASTRATI A, MEHILLl J, SCHLOTTERBERK K, et 01. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: A randomized controlledtrial[J]. JAMA, 2004, 291(8): 947-954.

共引文献2310

同被引文献102

引证文献11

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部